Comparison of Clinical Features of Arrhythmogenic Right Ventricular Cardiomyopathy in Men Versus Women

被引:72
作者
Bauce, Barbara [1 ]
Frigo, Gianfranco [1 ]
Marcus, Frank I. [2 ]
Basso, Cristina [3 ]
Rampazzo, Alessandra [4 ]
Maddalena, Francesco [1 ]
Corrado, Domenico [1 ]
Winnicki, Mikolaj [1 ]
Daliento, Luciano [1 ]
Rigato, Ilaria [1 ]
Steriotis, Alexandros [1 ]
Mazzotti, Elisa [1 ]
Thiene, Gaetano [3 ]
Nava, Andrea [1 ]
机构
[1] Univ Padua, Sch Med, Dept Cardiothorac & Vasc Sci, Padua, Italy
[2] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA
[3] Univ Padua, Sch Med, Dept Medicodiagnost Sci & Special Therapies, Padua, Italy
[4] Univ Padua, Sch Med, Dept Biol, Padua, Italy
关键词
D O I
10.1016/j.amjcard.2008.06.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease characterized by myocardial necrosis followed by fibrous-fatty replacement. The pathologic process constitutes the basis for ventricular arrhythmias due to re-entrant circuits. Even if this genetic disease is transmitted in the majority of cases with autosomal dominant trait, in all reported series ARVC is prevalent in men. In this study we investigate the impact that gender may have on clinical presentation in a large series of patients with ARVC. A total of 171 consecutive patients (mean 29 +/- 12 years, range 13 to 65) affected by ARVC were examined with family and personal history, 12-lead electrocardiogram (ECG), 24-hour ECG, signal-averaged ECG, and echocardiogram. Moreover, electrophysiological study and ventricular angiography were performed in selected cases. In the 171 subjects, 71% were men and 29% women (p = 0.02). No gender differences were found considering the age at the time of diagnosis and of study enrolment and the prevalence of index cases and family members. The genders differed in prevalence of abnormal ECG (69% vs 52%, p = 0.036) and presence of late potentials (60% vs 40%, p = 0.01). Moreover, men had larger right ventricular dimensions and practiced competitive sports more frequently (26% vs 14%, p < 0.001). Nonetheless, gender was not associated with a high incidence of life-threatening ventricular arrhythmias or with a poor outcome. In conclusion, our data show that diagnosis of ARVC is less common in female patients, who present a higher prevalence of mild forms. Nonetheless, the degree of electrical instability does not differ significantly between genders in affected subjects. Even if ARVC remains mainly a male disease, gender does not have a role in patients' outcome. The cause of the under-representation of women is not clear, even if potentially important factors such as sexual hormones and physical activity could play a role. (c) 2008 Elsevier Inc. All rights reserved. (Am J Cardiol 2008;102: 1252-1257)
引用
收藏
页码:1252 / 1257
页数:6
相关论文
共 29 条
[1]   A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair [J].
Alcalai, R ;
Metzger, S ;
Rosenheck, S ;
Meiner, V ;
Chajek-Shaul, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :319-327
[2]   Arrhythmogenic right ventricular cardiomyopathy - Dysplasia, dystrophy, or myocarditis? [J].
Basso, C ;
Thiene, G ;
Corrado, D ;
Angelini, A ;
Nava, A ;
Valente, M .
CIRCULATION, 1996, 94 (05) :983-991
[3]   Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations [J].
Bauce, B ;
Basso, C ;
Rampazzo, A ;
Beffagna, G ;
Daliento, L ;
Frigo, G ;
Malacrida, S ;
Settimo, L ;
Danieli, G ;
Thiene, G ;
Nava, A .
EUROPEAN HEART JOURNAL, 2005, 26 (16) :1666-1675
[4]   Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 [J].
Beffagna, G ;
Occhi, G ;
Nava, A ;
Vitiello, L ;
Ditadi, A ;
Basso, C ;
Bauce, B ;
Carraro, G ;
Thiene, G ;
Towbin, JA ;
Danieli, GA ;
Rampazzo, A .
CARDIOVASCULAR RESEARCH, 2005, 65 (02) :366-373
[5]   Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with Arrhythmogenic right ventricular cardiomyopathy/dysplasia [J].
Corrado, D ;
Leoni, L ;
Link, MS ;
Della Bella, P ;
Gaita, F ;
Curnis, A ;
Salerno, JU ;
Igidbashian, D ;
Raviele, A ;
Disertori, M ;
Zanotto, G ;
Verlato, R ;
Vergara, G ;
Delise, P ;
Turrini, P ;
Basso, C ;
Naccarella, F ;
Maddalena, F ;
Estes, NAM ;
Buja, G ;
Thiene, G .
CIRCULATION, 2003, 108 (25) :3084-3091
[6]   Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study [J].
Corrado, D ;
Basso, C ;
Thiene, G ;
McKenna, WJ ;
Davies, MJ ;
Fontaliran, F ;
Nava, A ;
Silvestri, F ;
BlomstromLundqvist, C ;
Wlodarska, EK ;
Fontaine, G ;
Camerini, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (06) :1512-1520
[7]   Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2 [J].
Dalal, D ;
Molin, LH ;
Piccini, J ;
Tichnell, C ;
James, C ;
Bomma, C ;
Prakasa, K ;
Towbin, JA ;
Marcus, FI ;
Spevak, PJ ;
Bluemke, DA ;
Abraham, T ;
Russell, SD ;
Calkins, H ;
Judge, DP .
CIRCULATION, 2006, 113 (13) :1641-1649
[8]  
FOALE R, 1986, BRIT HEART J, V56, P33
[9]   Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy [J].
Gerull, B ;
Heuser, A ;
Wichter, T ;
Paul, M ;
Basson, CT ;
McDermott, DA ;
Lerman, BB ;
Markowitz, SM ;
Ellinor, PT ;
MacRae, CA ;
Peters, S ;
Grossmann, KS ;
Michely, B ;
Sasse-Klaassen, S ;
Birchmeier, W ;
Dietz, R ;
Breithardt, G ;
Schulze-Bahr, E ;
Thierfelder, L .
NATURE GENETICS, 2004, 36 (11) :1162-1164
[10]   The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) [J].
Hodgkinson, KA ;
Parfrey, PS ;
Bassett, AS ;
Kupprion, C ;
Drenckhahn, J ;
Norman, MW ;
Thierfelder, L ;
Stuckless, SN ;
Dicks, EL ;
McKenna, WJ ;
Connors, SP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :400-408